Grant: Alliance Grants
McGill University
$206,800.00
Nb-based anodes to enable safe high energy and power batteries for medical devices
EF 2023-24
Résumé
Rechargeable batteries play important roles in implantable medical devices such as deep-brain stimulators to suppress tremors. In such applications, safety is of primary importance. The state-of-the-art anode for such batteries is lithium titanate that operates at a high potential mitigating safety concerns. However, high potential results in a significantly reduced energy density, thereby limiting the applications of these batteries. New Nb-based anode materials are promising in that they continue to operate at safe potentials but allow to nearly double the lithium storage and can be operated at higher rates giving a higher power. However, these materials have, to date, not been integrated into implantable devices due to detrimental transformations during battery use such as particle cracking. Herein, in-situ characterization will be used to fully understand these transformations in order to design a material that is more resilient under the conditions required for implantable devices. Then, a wide variety of material compositions will be screened in high-throughput fashion in order to mitigate these physical limitations. Furthermore, machine-learning algorithms will be utilized to dramatically increase the number of explored materials and predict to what extent co-substitution may be beneficial. In collaboration with our industrial partner, Medtronic Inc., the newly developed materials will be tested under realistic conditions to confirm their viability for medical devices. The development of these higher energy safe batteries will enable new implantable devices in the neuromodulation category and wearable devices such as sensor/monitors (e.g. glucose sensors). These new economic opportunities are important for Canadians both in terms of improved personal health and for the benefits to Medtronic manufacturing facilities in Canada.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
570416-2021
Name nom
McCalla, Eric ERM
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2021
Award amount
206800
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
305
Area of application group en
Energy resources
Area of application group fr
Ressources d'énergie
Area of application en
Energy storage and conversion
Area of application fr
Stockage et transformation de l'énergie
Research subject code
3401
Research subject group en
Physical chemistry
Research subject group fr
Electrochemistry
Research subject en
Chimie physique
Research subject fr
Électrochimie
Application title
Nb-based anodes to enable safe high energy and power batteries for medical devices
Keyword
computational chemistry; high power anodes; high-throughput material development; in-situ electrochemistry; Li-ion batteries; machine-learning; Nb-based materials; scanning electrochemical microscopy
Application summary
Rechargeable batteries play important roles in implantable medical devices such as deep-brain stimulators to suppress tremors. In such applications, safety is of primary importance. The state-of-the-art anode for such batteries is lithium titanate that operates at a high potential mitigating safety concerns. However, high potential results in a significantly reduced energy density, thereby limiting the applications of these batteries. New Nb-based anode materials are promising in that they continue to operate at safe potentials but allow to nearly double the lithium storage and can be operated at higher rates giving a higher power. However, these materials have, to date, not been integrated into implantable devices due to detrimental transformations during battery use such as particle cracking. Herein, in-situ characterization will be used to fully understand these transformations in order to design a material that is more resilient under the conditions required for implantable devices. Then, a wide variety of material compositions will be screened in high-throughput fashion in order to mitigate these physical limitations. Furthermore, machine-learning algorithms will be utilized to dramatically increase the number of explored materials and predict to what extent co-substitution may be beneficial. In collaboration with our industrial partner, Medtronic Inc., the newly developed materials will be tested under realistic conditions to confirm their viability for medical devices. The development of these higher energy safe batteries will enable new implantable devices in the neuromodulation category and wearable devices such as sensor/monitors (e.g. glucose sensors). These new economic opportunities are important for Canadians both in terms of improved personal health and for the benefits to Medtronic manufacturing facilities in Canada.